Anumana’s ECG PH Early Detection AI Algorithm Gets Breakthrough Device Designation
The U.S. FDA granted Anumana Breakthrough Device Designation to its AI-enhanced, ECG-based Pulmonary Hypertension Early Detection Algorithm.
The U.S. FDA granted Anumana Breakthrough Device Designation to its AI-enhanced, ECG-based Pulmonary Hypertension Early Detection Algorithm.
GE Healthcare announces that it has received U.S. FDA 510(k) clearance for an artificial intelligence algorithm to help clinicians assess endotracheal tube placements.
EHR systems are well suited for an automated process such as natural language processing, AI that could improve patient care, reports Health Tech.
The U.S. FDA granted Anumana Breakthrough Device Designation to its AI-enhanced, ECG-based Pulmonary Hypertension Early Detection Algorithm.
Here’s a look at three ways AI is streamlining physicians’ workflows and care delivery: enabling more accurate diagnoses earlier, boosting patient engagement for better outcomes, and providing quality data.
Read MoreCOVID-19 has spurred lasting digital transformation within the healthcare industry through de-identification of patient data and supply chain decisions informed by predictive analytics.
Read MoreBy leveraging cloud computing with continuous arrhythmia monitoring to create a reliable platform with accurate data collection, an ambulatory cardiac monitor optimizes AI solutions.
Read MoreProviders can identify codes that can be integrated into the EHR using simple steps through advanced risk adjustment analytics.
Read MoreTrusted Revenue Innovation for Smart Healthcare (TRISH) is designed to analyze and handle the most problematic areas of the revenue cycle.
Read MoreVivid Ultra Edition cardiovascular ultrasound features leverage AI-driven, neural network-based algorithms to deliver repeatable and faster measurements in 2D echo imaging.
Read MoreResearchers and provider organizations are finding solutions to issues preventing the use of big data analytics in healthcare.